|
|
 Columbia’s
Jeffrey Lieberman
Takes On Schizophrenia
Schizophrenia is the prototypic mental illness of our
time. The condition affects one percent of the population,
yet its cause is still unknown and the diagnosis is still
based on symptoms—the hallucinations and delusions known as
"positive" symptoms, and the "negative" symptoms that
include apathy, social withdraw, and flattened affect—rather
than the presence of any identifiable molecular abnormality,
or a diagnostic test. The progression of the disorder was
thought to be inexorable—a downward spiral into a hopeless
state of chronic psychosis and disability.
This dire prognosis, however, has been revised radically in
the past decade, thanks in large part to the work of the
Columbia University psychiatrist Jeffrey A. Lieberman. In
the current update to Thomson Scientific’s
Essential
Science IndicatorsSM database, based on
papers published and cited over the last ten years,
Lieberman currently ranks among the top 20 most-cited
authors in psychiatry/ psychology...read•> |
|
 |
 The
Large and Small of Australian Research
For
its latest survey of university and institutional research, Science Watch
returns to Australia, last covered more than a decade ago (7[4]: 1-2,
July/August 1996). In this update, Australian institutions are ranked according
to two main measures: impact (average citations per paper) and total citations,
based on papers published and cited in Thomson Scientific-indexed journals
between 2002 and 2006. |
|
20-Year Overview
Affirms Breast-Cancer
Regimen |
Comet Gets Dusted
After Scientists Order
a Hit |
Dye, Solar Cells, Dye!
Improving Photovoltaics |
T-Cell Complexity Deepens
With Trio of Th17
Studies |
|
The Research Services
Group
of Thomson Scientific.
 |
|
|
.
